Immunology Experts

Claudio Anasetti

Deparment of Immunology
Moffitt Cancer Center
United States of America


Dr. Claudio Anasetti is affiliated to Deparment of Immunology, Moffitt Cancer Center. Dr. Claudio Anasetti is currently providing services as Researcher. Dr. Claudio Anasetti has authored and co-authored multiple peer-reviewed scientific papers and presented works at many national and International conferences. Dr. Claudio Anasetti contributions have acclaimed recognition from honourable subject experts around the world. Dr. Claudio Anasetti is actively associated with different societies and academies. Dr. Claudio Anasetti academic career is decorated with several reputed awards and funding. Dr. Claudio Anasetti research interests include antibody targeting of the T-cell receptor and CD28 to prevent GVHD in mouse models and human transplants.

Research Interest

Antibody targeting of the T-cell receptor and CD28 to prevent GVHD in mouse models and human transplants


  • Locke FL, Pidala J, Storer B, Martin PJ, Pulsipher MA, Chauncey TR, Jacobsen N, Kröger N, Walker I, Light S, Shaw BE. CD25 Blockade Delays Regulatory T Cell Reconstitution and Does Not Prevent Graft-versus-Host Disease After Allogeneic Hematopoietic Cell Transplantation. Biology of Blood and Marrow Transplantation. 2017 Mar 31;23(3):405-11.

  • Betts BC, Pidala J, Kim J, Mishra A, Nishihori T, Perez L, Ochoa-Bayona JL, Khimani F, Walton K, Bookout R, Nieder M. IL-2 promotes early Treg reconstitution after allogeneic hematopoietic cell transplantation. Haematologica. 2017 May 1;102(5):948-57.

  • Bashey A, Zhang MJ, McCurdy SR, St. Martin A, Argall T, Anasetti C, Ciurea SO, Fasan O, Gaballa S, Hamadani M, Munshi P. Mobilized peripheral blood stem cells versus unstimulated bone marrow as a graft source for T-cell–replete haploidentical donor transplantation using post-transplant cyclophosphamide. Journal of Clinical Oncology. 2017 Jun 23:JCO-2017.

Global Experts from United States of America

Global Experts in Subject

Share This Profile